[Breaking] L&C Bio Surges 7%... VI Repeatedly Triggered on KRX and NXT
L&C Bio (290650) showed a sharp surge in the afternoon session on the 14th, with the Volatility Interruption (VI) mechanism being triggered in succession on the Korea Exchange (KRX) and NXTTrade (NXT). As of 1:55 p.m. on the 14th, L&C Bio was trading at 62,300 won, up 4,100 won (+7.04%) from the pr
![[Breaking] L&C Bio Surges 7%... VI Repeatedly Triggered on KRX and NXT](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F581911%2Fa630da1c47d6049c%2Foriginal.webp&w=1920&q=75)
L&C Bio (290650) showed a sharp surge in the afternoon session on the 14th, with the Volatility Interruption (VI) mechanism being triggered in succession on the Korea Exchange (KRX) and NXTTrade (NXT).
As of 1:55 p.m. on the 14th, L&C Bio was trading at 62,300 won, up 4,100 won (+7.04%) from the previous trading day.
A static VI was triggered on the KRX at 1:37:53 p.m. and released at 1:40:03 p.m. Then, a static VI was also triggered on NXT at 1:41:04 p.m. and lifted at 1:43:04 p.m. With VIs being triggered in succession on the two trading markets at intervals of about three minutes, attention is focused on the stock's intraday movement.
The VI is a system that temporarily applies single-price trading to ease price fluctuations when a stock price moves sharply beyond a certain range.
While L&C Bio has shown an upward trend since the afternoon, there is a possibility that intraday volatility may expand, making it necessary to monitor the stock's future trajectory.
◆ Rights Issue Final Issue Price Confirmed... Designated as Overheated Short-Selling Stock
L&C Bio announced in a regulatory filing that it has finalized the final issue price of its rights offering at 39,100 won per share. The number of shares to be issued is 3.7 million common shares.
In addition, according to the filing, L&C Bio was designated as an overheated short-selling stock on the 14th, and short-selling trades are prohibited in the regular market and after-hours market that day. However, some transactions for market-making and liquidity-provision purposes are exceptionally permitted.
With market-related news continuing, including the rights offering filing and the designation as an overheated short-selling stock, attention is focused on where L&C Bio will close out its gains today.
[※ This article is intended to convey market trends and is not intended to recommend investment in any specific stock.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] Baropharm Shares Fall 13% on First Day of KOSDAQ Listing... Growth of Pharmacy Order Aggregation Platform Is Key](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F07%2F587624%2F92a22c34058cf1b1%2Fvariants%2Fhero.webp&w=1920&q=75)
![[Featured Stocks] Simtech Holdings Surges Over 20%... Isu Petasys, Korea Circuit, Simtech, and Other Semiconductor Substrate Stocks Broadly Higher](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F06%2F579769%2F6712719b6f068855%2Fvariants%2Fhero.webp&w=1920&q=75)

